A detailed history of High Vista Strategies LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 58,001 shares of ARVN stock, worth $1.11 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
58,001
Previous 51,122 13.46%
Holding current value
$1.11 Million
Previous $1.36 Million 5.0%
% of portfolio
0.56%
Previous 0.55%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.66 - $32.73 $162,757 - $225,149
6,879 Added 13.46%
58,001 $1.43 Million
Q1 2024

May 15, 2024

BUY
$36.38 - $52.31 $1.86 Million - $2.67 Million
51,122 New
51,122 $2.11 Million
Q1 2023

May 15, 2023

BUY
$26.15 - $37.26 $83,758 - $119,343
3,203 Added 20.03%
19,197 $524,000
Q4 2022

Feb 14, 2023

SELL
$32.47 - $57.24 $73,447 - $129,476
-2,262 Reduced 12.39%
15,994 $547,000
Q3 2022

Nov 14, 2022

BUY
$41.87 - $57.99 $107,605 - $149,034
2,570 Added 16.38%
18,256 $812,000
Q2 2022

Aug 15, 2022

BUY
$36.01 - $74.24 $564,852 - $1.16 Million
15,686 New
15,686 $660,000
Q3 2020

Nov 16, 2020

SELL
$22.99 - $36.34 $332,596 - $525,730
-14,467 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$29.88 - $56.74 $432,273 - $820,857
14,467 New
14,467 $485,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.